The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early response marker during pembrolizumab treatment in metastatic urothelial cancer: Temporal shift in peripheral CD4 T cells expressing chemokine receptors.
 
Maud Rijnders
No Relationships to Disclose
 
Hayri Emrah Balcioglu
No Relationships to Disclose
 
Debbie Robbrecht
Consulting or Advisory Role - Bayer; Cantargia AB; Faron Pharmaceuticals; Servier (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Joost L. Boormans
Consulting or Advisory Role - Janssen; Merck Sharp & Dohme
Speakers' Bureau - MML Medical
 
Maureen J.B. Aarts
No Relationships to Disclose
 
Paul Hamberg
No Relationships to Disclose
 
Jens Voortman
Consulting or Advisory Role - MSD Oncology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Ipsen; Merck; Pfizer; Pfizer; Sanofi; TEVA
 
Hans Westgeest
Honoraria - Roche
Travel, Accommodations, Expenses - Ipsen
 
Ronald De Wit
Honoraria - Merck Sharp & Dohme; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen; Merck Sharp & Dohme; Roche/Genentech; Sanofi
Research Funding - Bayer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Lilly
 
Martijn P. Lolkema
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Johnson & Johnson; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); Johnson & Johnson (Inst); Merck Sharp & Dohme (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Merck Sharp & Dohme
 
Astrid Aplonia Maria Van Der Veldt
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Bayer; MSD Oncology; Novartis; Roche; Roche
 
Reno Debets
No Relationships to Disclose